Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted while President Donald Trump announced a deal with drugmakers to lower obesity drug prices.
Details of the Incident
- The event was interrupted on Thursday as Gordon Findlay, believed to be Novo Nordisk's global brand director, collapsed.
- President Trump was speaking about a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for obesity treatments Zepbound and Wegovy.
- David Ricks, CEO of Eli Lilly, noticed Findlay's condition and asked, "Are you OK? Gordon, are you OK?"
Immediate Response
Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, quickly intervened as Findlay fell to his knees and collapsed.
"Are you OK? Gordon, are you OK?" — David Ricks, Eli Lilly CEO
The press was then asked to leave the room as the situation was addressed. Health and Human Services Secretary was also present during the incident.
Summary
This unexpected medical emergency occurred amid an announcement aiming to make obesity drugs more affordable and accessible.
Author's Note
The incident underscores the intense pressure at high-profile political events and the importance of immediate medical attention.
More News
- Macclesfield see off Slough in extra-time
- How many syllables in breezes?
- Skippylongstocking excels in Harlan’s Holiday Stakes
- Evidence of burial ground at Tuam mother and baby home
- Macclesfield FC line-up - Emirates FA Cup
- Suryakumar Yadav Becomes Mumbai's Top T20 Run-Scorer
- Suryakumar Yadav leads as notable names return to India's side for their T20I series
- 10 Slow-Paced Towns In Idaho Where You Can Live Peacefully, Happily, And Debt-Free
- Column: Toy drive for Mutual Ground stirs memories of Aurora City Council member’s own traumatic childhood
- The journey continues: Courtois shines at San Mamés